Oncoinvent Solutions AS
3 clinical trials · Sponsor
◉ Watch Oncoinvent Solutions AS
| Record | Firm | Date |
|---|---|---|
| A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery (NCT06504147) | Oncoinvent Solutions AS | 2024-06-15 |
| Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis (NCT03732768) | Oncoinvent Solutions AS | 2020-06-08 |
| Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC (NCT03732781) | Oncoinvent Solutions AS | 2020-05-27 |
Track Oncoinvent Solutions AS automatically
Every clearance here is in the API, with alerts when new ones post.